Forty older adults with chronic musculoskeletal pain received either 4 grams daily of krill oil (containing 1,288 mg EPA+DHA) or placebo for 12 weeks. The krill oil group experienced a 41% reduction in the number of painful body sites and showed trends toward lower pain intensity scores compared to placebo. Their omega-3 index increased from 4.3% to 7.4%, approaching cardioprotective levels. This represents a compelling intersection of pain management and healthy aging research. Chronic musculoskeletal pain affects over half of adults over 65, driving disability and healthcare costs while limiting conventional treatment options due to medication side effects. The phospholipid-bound omega-3s in krill oil may offer superior bioavailability compared to fish oil, while astaxanthin provides additional anti-inflammatory benefits. However, this pilot study's small sample size (n=40) and exploratory endpoints require cautious interpretation. The 95% retention rate and high acceptability scores suggest older adults find krill oil tolerable, addressing a key barrier to omega-3 supplementation. While promising, these preliminary findings need validation in larger trials before krill oil can be recommended as a standard pain management strategy for aging populations.